C
ChemoCentryx Inc
F:2CX
ChemoCentryx Inc
F:2CX
Price:
51.89
EUR
Market Cap:
€3.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
ChemoCentryx Inc
F:2CX
|
US |
|
N
|
Ningbo Sunrise Elc Technology Co Ltd
SZSE:002937
|
CN |
|
MHM Automation Ltd
NZX:MHM
|
NZ |
|
Y
|
Yung Chi Paint & Varnish Mfg Co Ltd
TWSE:1726
|
TW |
Balance Sheet
Balance Sheet Decomposition
ChemoCentryx Inc
ChemoCentryx Inc
Balance Sheet Decomposition is not available for
ChemoCentryx Inc
ChemoCentryx Inc
Balance Sheet
ChemoCentryx Inc
ChemoCentryx Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
9
|
10
|
16
|
13
|
12
|
40
|
28
|
39
|
32
|
50
|
|
| Cash Equivalents |
9
|
10
|
16
|
13
|
12
|
40
|
28
|
39
|
32
|
50
|
|
| Short-Term Investments |
94
|
123
|
57
|
59
|
106
|
87
|
149
|
134
|
404
|
215
|
|
| Total Receivables |
1
|
0
|
0
|
0
|
30
|
51
|
2
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
30
|
51
|
2
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
5
|
3
|
|
| Total Current Assets |
105
|
134
|
74
|
72
|
149
|
180
|
181
|
174
|
442
|
269
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
52
|
57
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
52
|
57
|
|
| Accumulated Depreciation |
6
|
7
|
7
|
8
|
8
|
8
|
8
|
9
|
7
|
9
|
|
| Long-Term Investments |
16
|
17
|
41
|
5
|
6
|
8
|
0
|
30
|
24
|
98
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
| Total Assets |
122
N/A
|
152
+25%
|
117
-23%
|
78
-33%
|
156
+99%
|
189
+21%
|
183
-3%
|
209
+14%
|
519
+148%
|
426
-18%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
13
|
7
|
|
| Accrued Liabilities |
6
|
6
|
7
|
4
|
8
|
8
|
12
|
19
|
20
|
26
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
19
|
|
| Other Current Liabilities |
4
|
0
|
0
|
1
|
29
|
24
|
51
|
39
|
13
|
11
|
|
| Total Current Liabilities |
11
|
7
|
8
|
6
|
38
|
33
|
64
|
59
|
52
|
63
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
5
|
20
|
20
|
18
|
5
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
68
|
72
|
85
|
64
|
64
|
72
|
|
| Total Liabilities |
12
N/A
|
7
-41%
|
8
+18%
|
6
-33%
|
106
+1 793%
|
110
+4%
|
169
+53%
|
143
-15%
|
133
-7%
|
140
+5%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
134
|
173
|
220
|
267
|
307
|
289
|
375
|
430
|
485
|
617
|
|
| Additional Paid In Capital |
245
|
318
|
328
|
340
|
357
|
369
|
389
|
496
|
871
|
904
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
110
N/A
|
145
+32%
|
109
-25%
|
73
-33%
|
50
-31%
|
79
+59%
|
15
-81%
|
66
+349%
|
386
+484%
|
286
-26%
|
|
| Total Liabilities & Equity |
122
N/A
|
152
+25%
|
117
-23%
|
78
-33%
|
156
+99%
|
189
+21%
|
183
-3%
|
209
+14%
|
519
+148%
|
426
-18%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
36
|
43
|
43
|
44
|
48
|
49
|
51
|
60
|
70
|
70
|
|
Switch to:
Switch to:
See Also
Discover More
